1

Dren Bio

Oncology

www.drenbio.com

HBM contact: Dr Chandra P. Leo

Company status: private

Dren Bio is a biotechnology company developing powerful protein engineering technologies to deplete cells, protein aggregates and other disease-causing agents. Dren’s lead programs are initially focused on hematologic neoplasms and solid cancers.

© HBM Partners AG  |  Bundesplatz 1  |  6300 Zug, Switzerland  |  Phone  +41 43 888 7171